HMS Researchers Use Machine Learning to Recommend Drugs for Alzheimer's Disease Clinical Trials


Harvard Medical School researchers developed a strategy that uses machine learning to recommend drugs as candidates for clinical trials for Alzheimer's disease, according to an article published in the journal Nature Communications last month.

Duplicate Docs Excel Report

None found

Similar Docs  Excel Report  more

None found